FI963679A0 - Stabiloitu koostumus peptidien antamiseksi suun kautta - Google Patents

Stabiloitu koostumus peptidien antamiseksi suun kautta

Info

Publication number
FI963679A0
FI963679A0 FI963679A FI963679A FI963679A0 FI 963679 A0 FI963679 A0 FI 963679A0 FI 963679 A FI963679 A FI 963679A FI 963679 A FI963679 A FI 963679A FI 963679 A0 FI963679 A0 FI 963679A0
Authority
FI
Finland
Prior art keywords
pct
oral administration
spheres
sec
peptides
Prior art date
Application number
FI963679A
Other languages
English (en)
Swedish (sv)
Other versions
FI963679A (fi
FI114688B (fi
Inventor
Anne Fjellestad-Paulsen
Christina Ahlm-Soederberg
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of FI963679A0 publication Critical patent/FI963679A0/fi
Publication of FI963679A publication Critical patent/FI963679A/fi
Application granted granted Critical
Publication of FI114688B publication Critical patent/FI114688B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
FI963679A 1994-03-18 1996-09-17 Stabiloitu koostumus peptidien antamiseksi suun kautta FI114688B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9400918A SE9400918L (sv) 1994-03-18 1994-03-18 Stabiliserad komposition för oral administrering av peptider
PCT/SE1995/000249 WO1995025534A1 (en) 1994-03-18 1995-03-09 Stabilized composition for oral administration of peptides

Publications (3)

Publication Number Publication Date
FI963679A0 true FI963679A0 (fi) 1996-09-17
FI963679A FI963679A (fi) 1996-09-17
FI114688B FI114688B (fi) 2004-12-15

Family

ID=20393330

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963679A FI114688B (fi) 1994-03-18 1996-09-17 Stabiloitu koostumus peptidien antamiseksi suun kautta

Country Status (24)

Country Link
US (1) US5763405A (fi)
EP (1) EP0752877B1 (fi)
JP (1) JP3249970B2 (fi)
CN (1) CN1143911A (fi)
AT (1) ATE194290T1 (fi)
AU (1) AU679852B2 (fi)
BR (1) BR9506989A (fi)
CA (1) CA2183862C (fi)
CZ (1) CZ285810B6 (fi)
DE (1) DE69517801T2 (fi)
DK (1) DK0752877T3 (fi)
ES (1) ES2149979T3 (fi)
FI (1) FI114688B (fi)
GR (1) GR3034440T3 (fi)
HU (1) HU214826B (fi)
NO (1) NO316055B1 (fi)
NZ (1) NZ283462A (fi)
PL (1) PL181866B1 (fi)
PT (1) PT752877E (fi)
RO (1) RO115123B1 (fi)
RU (1) RU2140790C1 (fi)
SE (1) SE9400918L (fi)
SK (1) SK281640B6 (fi)
WO (1) WO1995025534A1 (fi)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922680A (en) * 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
SE9604341D0 (sv) 1996-11-26 1996-11-26 Ferring Bv Hepta-peptide oxytocin analogue
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US8088734B2 (en) 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
ES2236640T3 (es) * 2003-04-30 2005-07-16 Ferring B.V. Forma posologica de la desmopresina.
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
DE60301351T2 (de) 2003-07-25 2006-01-19 Ferring B.V. Pharmazeutische Desmopressin-Zubereitung als feste Darreichungsform und Methode zu ihrer Herstellung
PT1530967E (pt) * 2003-11-13 2006-09-29 Ferring Bv Embalagem blister e uma forma de dosagem solida que compreende desmopressina.
US7018653B2 (en) 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
JP5451613B2 (ja) 2007-08-06 2014-03-26 アラーガン、インコーポレイテッド デスモプレシン薬物送達のための方法及びデバイス
ES2319054B1 (es) 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
ES2710454T3 (es) * 2008-05-21 2019-04-25 Ferring Bv Desmopresina bucodispersable para aumentar el periodo inicial de sueño ininterrumpido por nocturia
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
EP2161030A1 (en) * 2008-09-09 2010-03-10 Rijksuniversiteit te Groningen Oxytocin formulations and uses thereof
PL3679941T3 (pl) 2009-06-18 2023-04-17 Serenity Pharmaceuticals Llc Bezpieczne podawanie desmopresyny
ES2581837T3 (es) * 2010-07-26 2016-09-07 Université De Genève Composiciones que comprenden polímeros preparados a partir de ácidos 2-hidroxi alquil
CN102146122A (zh) * 2010-11-12 2011-08-10 深圳市健元医药科技有限公司 一种具有宫缩作用药物的生产工艺
SE536091C2 (sv) * 2011-04-14 2013-04-30 Pep Tonic Medical Ab Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
PL3200764T3 (pl) * 2014-10-01 2020-12-28 Oxytone Bioscience B.V. Rozpadająca się w jamie ustnej stała farmaceutyczna jednostka dawkowania zawierająca substancję kontrolującą poród
WO2019180561A1 (en) * 2018-03-20 2019-09-26 Mankind Pharma Ltd. Stable pharmaceutical composition of vasopressin
CN112839632A (zh) 2018-09-20 2021-05-25 莱沃疗法公司 稳定的鼻内卡贝缩宫素制剂
CN112969450B (zh) 2018-09-20 2023-05-30 阿卡蒂亚药品公司 卡贝缩宫素药物产品及用于制备其的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH495957A (de) * 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
US4271068A (en) * 1968-05-10 1981-06-02 Ciba-Geigy Corporation Process for the manufacture of cystine-containing peptides
CH517705A (de) * 1969-12-16 1972-01-15 Ciba Geigy Ag Verfahren zur Herstellung von Cystin-haltigen Peptiden
US3929758A (en) * 1974-09-12 1975-12-30 Armour Pharma Cyclization of cysteine-containing peptides
US4033940A (en) * 1975-11-12 1977-07-05 Armour Pharmaceutical Company Cyclization of peptides
US4093610A (en) * 1977-01-31 1978-06-06 American Home Products Corporation Process for producing triglycyl-lysine vasopressin and intermediates therefor
US4216141A (en) * 1978-07-19 1980-08-05 The Salk Institute For Biological Studies Method for cyclization of peptides
DE2923787A1 (de) * 1979-06-12 1980-12-18 Max Planck Gesellschaft Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
IE56021B1 (en) * 1982-10-13 1991-03-27 Akzo Nv Peptides
IL77186A0 (en) * 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
US5066716A (en) * 1988-12-13 1991-11-19 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthesis of chloroacetyl and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides
SE9300937L (sv) * 1993-03-19 1994-09-20 Anne Fjellestad Paulsen Komposition för oral administrering av peptider
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US5500413A (en) * 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
PL176317B1 (pl) * 1993-06-29 1999-05-31 Ferring Bv Wodny preparat do donosowego stosowania desmopresyny

Also Published As

Publication number Publication date
JPH10503467A (ja) 1998-03-31
HUT74878A (en) 1997-02-28
DK0752877T3 (da) 2000-10-16
RO115123B1 (ro) 1999-11-30
ATE194290T1 (de) 2000-07-15
CA2183862A1 (en) 1995-09-28
FI963679A (fi) 1996-09-17
PT752877E (pt) 2000-12-29
SE9400918D0 (sv) 1994-03-18
PL316412A1 (en) 1997-01-06
CN1143911A (zh) 1997-02-26
WO1995025534A1 (en) 1995-09-28
DE69517801D1 (de) 2000-08-10
CA2183862C (en) 2001-10-23
SK118596A3 (en) 1997-04-09
US5763405A (en) 1998-06-09
SK281640B6 (sk) 2001-06-11
EP0752877B1 (en) 2000-07-05
EP0752877A1 (en) 1997-01-15
NO963884D0 (no) 1996-09-17
PL181866B1 (pl) 2001-09-28
BR9506989A (pt) 1997-09-16
GR3034440T3 (en) 2000-12-29
NZ283462A (en) 1997-03-24
NO963884L (no) 1996-09-17
CZ285810B6 (cs) 1999-11-17
SE9400918L (sv) 1995-09-19
ES2149979T3 (es) 2000-11-16
JP3249970B2 (ja) 2002-01-28
HU9602544D0 (en) 1996-11-28
AU2151795A (en) 1995-10-09
RU2140790C1 (ru) 1999-11-10
CZ267696A3 (en) 1997-05-14
HU214826B (hu) 1998-06-29
DE69517801T2 (de) 2001-02-22
FI114688B (fi) 2004-12-15
AU679852B2 (en) 1997-07-10
NO316055B1 (no) 2003-12-08

Similar Documents

Publication Publication Date Title
FI963679A0 (fi) Stabiloitu koostumus peptidien antamiseksi suun kautta
ES2135570T3 (es) Composicion para la administracion oral de peptidos.
KR100449538B1 (ko) 개별유니트의경구투여
EP0225189A3 (en) Targeted enteral delivery system
EA200200126A1 (ru) Гидродинамически сбалансированная пероральная система доставки лекарства
EP1275381A4 (en) SOLID COATED PREPARATIONS WITH TEMPERATURE RELEASE FOR ORAL ADMINISTRATION
IL142801A0 (en) Pharmaceutical compositions containing an adenosine analog
ES2006649A6 (es) Una composicion para depositarse sobre la superficie de un granulo de un producto farmaceutico y procedimiento para la obtencion de la misma.
SE8306367D0 (sv) Antidiuretiskt verkande farmaceutiskt preparat
HK1067299A1 (en) Pharmaceutical compositions containing terbinafineand use thereof
RU2449796C9 (ru) Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива
MX9709838A (es) Composiciones farmaceuticas estables que contienen hidratos de tiludronato y proceso para producir las composiciones farmaceuticas.
MX9802026A (es) Formulaciones farmaceuticas que contienen darifenacina.
NO964775L (no) Fast farmasöytisk adenosinholdig preparat
TH61079A (th) ยาเม็ดเคลือบฟิล์มสำหรับความปลอดภัยที่ดีขึ้นสำหรับทางเดินกระเพาะลำไส้ตอนบน
TH31107B (th) ยาเม็ดเคลือบฟิล์มสำหรับความปลอดภัยที่ดีขึ้นสำหรับทางเดินกระเพาะลำไส้ตอนบน

Legal Events

Date Code Title Description
MA Patent expired